I’ve been concentrating on Part 2 of my political reckoning, ‘This Party Sucks,’ which may have been promised last week but has been rescheduled for this Sunday morning.
It felt futile to post anything that hoped to compete with coverage of the Final Cass Report this week. That coverage has made for satisfying reading, of which I will borrow some so as to imprint the event on the TransMuted timeline of major happenings.
Also, keeping in mind the highly valued segment of readers who aren’t (yet) gender-obsessed and may not know what I’m talking about, I want to make sure it’s all explained here.
Four years ago, England’s National Health Service commissioned a highly respected pediatrician named Dr. Hilary Cass to conduct a systematic evidence review (SER) of ‘gender-affirming’ pediatric medicine. An SER gathers every study ever published on the question at hand, anywhere in the world, and ranks each according to its adherence to accepted scientific methods. Those that meet or exceed a quality baseline are further ranked and compared by examining their raw data. The goal is to sort for the most reliable evidence measured against the best objective standards, with the resulting data pointing to the best knowable conclusions that can be drawn about a given question at a point in time. Dr. Cass and her team delivered an Interim Report in July, 2022, and the Final Report last week.
Lots of great coverage can be found on Substack, such as today’s roundup by the LGBT Courage Coalition, which is where I learned about Scotland’s banning puberty blockers! Here’s an excerpt:
The Cass Review continues to reverberate out with more media coverage and policy changes on an international level, including the banning of puberty blockers in Scotland.
In the US, two high-profile OpEds have continued to highlight the findings of the Cass Review. The first, “The US needs a bipartisan, open-minded gender medicine commission”, was written by Lisa Selin-Davis and published in the Boston Globe. The second OpEd, “A new report roils debate on youth gender care,” was written by therapist Paul Garcia-Ryan and published in the Washington Post.
This move by the Washington Post is unprecedented and represents another significant milestone in the legacy media’s willingness to allow for more open debate of youth gender medicine.
This column by David Brooks in the New York Times delivers a thoughtful overview.
Now we’re all up to speed on the most consequential news event affecting ‘youth gender medicine’ thus far. The UK and Europe have all turned the corner, leaving the US, Canada, Australia and New Zealand to work out whether or when to extricate themselves from a series of unfortunate decisions that will have harmed a generation in irreversible ways.
I’ll be back in your in-box on Sunday!
Cheers,
Jenny